ArticleTranslational cancer research2025
Prognostic implication of endoplasmic reticulum stress-related gene signature in lung adenocarcinoma and its effect on tumor immunity.
Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Endoplasmic reticulum stress-related genes play a role in the prognosis of lung adenocarcinoma.Discover oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Endoplasmic reticulum stress (ERS) can affect the efficacy of anti-tumor therapy (chemotherapy, targeted therapy and immunotherapy) by regulating tumor immune microenvironment. This study aims to develop a prognostic prediction model based on the expression profiles of ERS-related genes to guide the treatment of lung adenocarcinoma (LUAD). Methods: The 16-gene prognostic signature was established to predict the prognosis of LUAD patients using The Cancer Genome Atlas (TCGA) database. We applied consensus clustering and found that LUAD could be divided into two groups based on the expression of Results: We successfully constructed a 16-gene prognostic signature and a nomogram to help individualize outcome prediction in LUAD. The ERS risk signature is an independent prognostic factor for LUAD patients, and a higher score indicates a poorer prognosis. Through consensus clustering based on the expression of Conclusions: The ERS-associated gene signature can effectively predict the prognosis of LUAD patients. In addition, we found that
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.